Emerging Therapeutic Company Investment and Deal Trends

New Clinical Development Success Rates 2011-2020 Report


Clinical Success Report


BIO, Informa Pharma Intelligence, and QLS Advisors have released a new report on clinical development success rates covering 2011-2020. The report includes comparisons of success rates across indications and modalities, regulatory factors, and predictive factors driving successes and failures in drug development. This new data will help shape risk profiles and valuation metrics across investment and pharma R&D portfolios.